+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Reusable Insulin Pens, Disposable Insulin Pens), By End Use (Hospitals & Clinics, Homecare), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 3989899
Description Jump to:
The global insulin delivery devices market size was estimated at USD 28.06 billion in 2030 and is expected to grow at a CAGR of 7.89% from 2024 to 2030. Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, the growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.

Technological innovations and advancements are an ongoing trend in this vertical. The high demand for advanced insulin delivery devices is supporting the adoption of recently launched innovative pen devices and portable pumps, which is estimated to boost the market growth. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices and the high cost of insulin analogs in diabetes care management are major factors restraining the growth of this industry.

The market's prominent competitors are taking different initiatives such as acquisition, funding, and product development to expand their product portfolio and enhance their manufacturing capacity. For instance, in October 2021, Eli Lilly partnered with Cipla, to market its Insulin products (Humalog and Trulicity) in India. Additionally, In June 2021, the company acquired Protomer Technologies, to strengthen its market presence. Further, Novo Nordisk, joined hands with Biocorp to develop a Bluetooth-enabled smart add-on device for their pen insulin injector.

Insulin Delivery Devices Market Report Highlights

  • The insulin pens segment was the largest revenue-generating category of this market in 2021. The pen is equipped with self-contained cartridges and offers ease in handling and less pain while injecting insulin. The advantages of these pen devices over other products are resulting in their growing popularity, thus serving as a vital factor in contributing to the sectorb s highest share in this market
  • The home care segment is estimated to be the fastest-growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients
  • North America is the leading regional sector and accounted for the largest revenue share in 2021 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting market growth
  • In Asia Pacific, the market is anticipated to grow fast during the forecast period. The high prevalence rate of diabetes in countries, such as China and India, is a major factor contributing to market expansion in this region

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Insulin Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rise in the prevalence of diabetes globally
3.2.1.2. Increasing geriatric population
3.2.1.3. Favorable government reimbursement scenario
3.2.1.4. Increasing awareness about diabetes preventive care
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulatory framework
3.2.2.2. High cost of devices
3.3. Insulin Delivery Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Insulin Delivery Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Insulin Delivery Devices Product Market Movement Analysis
4.3. Global Insulin Delivery Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Insulin Pens
4.4.1. Insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Reusable Insulin Pens
4.4.2.1. Reusable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Disposable Insulin Pens
4.4.3.1. Disposable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Insulin Pumps
4.5.1. Insulin pumps market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Patch Pumps
4.5.2.1. Patch pumps market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Tethered Pumps
4.5.3.1. Tethered pumps market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Insulin Pen Needles
4.6.1. Insulin pen needles market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Standard Pen Needles
4.6.2.1. Standard pen needles market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Safety Pen Needles
4.6.3.1. Safety pen needles market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Insulin Syringes
4.8. Other Products
Chapter 5. Insulin Delivery Devices Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Insulin Delivery Devices End Use Market Movement Analysis
5.3. Global Insulin Delivery Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals & Clinics
5.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Homecare
5.5.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Other End User
5.6.1. Other End Users market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Insulin Delivery Devices Market: Regional Estimates & Trend Analysis By Product, End Use
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Competitive scenario
6.5.1.3. Regulatory framework
6.5.1.4. Reimbursement structure
6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework
6.5.2.4. Reimbursement structure
6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework
6.5.3.4. Reimbursement structure
6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Competitive scenario
6.6.1.3. Regulatory framework
6.6.1.4. Reimbursement structure
6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement structure
6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement structure
6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Competitive scenario
6.6.4.3. Regulatory framework
6.6.4.4. Reimbursement structure
6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Competitive scenario
6.6.5.3. Regulatory framework
6.6.5.4. Reimbursement structure
6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Competitive scenario
6.6.6.3. Regulatory framework
6.6.6.4. Reimbursement structure
6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Competitive scenario
6.6.7.3. Regulatory framework
6.6.7.4. Reimbursement structure
6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Competitive scenario
6.6.8.3. Regulatory framework
6.6.8.4. Reimbursement structure
6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Competitive scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement structure
6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement structure
6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement structure
6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement structure
6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement structure
6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement structure
6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Competitive scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement structure
6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement structure
6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Competitive scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement structure
6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement structure
6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Competitive scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement structure
6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Competitive scenario
6.9.4.3. Regulatory framework
6.9.4.4. Reimbursement structure
6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2023
7.4. Company Position Analysis
7.5. Company Categorization (Emerging Players, Innovators and Leaders
7.6. Company Profiles
7.6.1. Novo Nordisk A/S
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Sanofi
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. Eli Lilly and Company
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Ypsomed AG
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Medtronic
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. Insulet Corporation
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. B. Braun SE
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. Owen Mumford Ltd.
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Tandem Diabetes Care, Inc.
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
7.6.9.5. Company overview
7.6.10. BD
7.6.10.1. Company overview
7.6.10.2. Financial performance
7.6.10.3. Product benchmarking
7.6.10.4. Strategic initiatives
7.6.10.5. Company overview
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America insulin delivery devices market, By country, 2018 - 2030 (USD Million)
Table 4 North America insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 5 North America insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 6 U.S insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 7 U.S insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 8 Canada insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 9 Canada insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 10 Mexico insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 11 Mexico insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 12 Europe insulin delivery devices market, By country, 2018 - 2030 (USD Million)
Table 13 Europe insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 14 Europe insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 15 UK insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 16 UK insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 17 Germany insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 18 Germany insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 19 France insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 20 France insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 21 Italy insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 22 Italy insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 23 Denmark insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 24 Denmark insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 25 Sweden insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 26 Sweden insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 27 Norway insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 28 Norway insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 29 Asia Pacific insulin delivery devices market, By country, 2018 - 2030 (USD Million)
Table 30 Asia Pacific insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 31 Asia Pacific insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 32 Japan insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 33 Japan insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 34 China insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 35 China insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 36 India insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 37 India insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 38 Australia insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 39 Australia insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 40 South Korea insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 41 South Korea insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 42 Thailand insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 43 Thailand insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 44 Latin America insulin delivery devices market, By Country, 2018 - 2030 (USD Million)
Table 45 Latin America insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 46 Latin America insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 47 Brazil insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 48 Brazil insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 49 Argentina insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 50 Argentina insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 51 Middle East & Africa insulin delivery devices market, By country, 2018 - 2030 (USD Million)
Table 52 Middle East & Africa insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 53 Middle East & Africa insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 54 South Africa insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 55 South Africa insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 58 UAE insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 59 UAE insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
Table 60 Kuwait insulin delivery devices market, By product, 2018 - 2030 (USD Million)
Table 61 Kuwait insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Insulin delivery devices market: market outlook
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 Penetration and growth prospect mapping
Fig. 17 Industry value chain analysis
Fig. 18 Insulin delivery devices market driver impact
Fig. 19 Insulin delivery devices market restraint impact
Fig. 20 Insulin delivery devices market: Product movement analysis
Fig. 21 Insulin delivery devices market: Product outlook and key takeaways
Fig. 22 Insulin pens market estimates and forecast, 2018 - 2030
Fig. 23 Reusable insulin pens market estimates and forecast, 2018 - 2030
Fig. 24 Disposable insulin pens market estimates and forecast, 2018 - 2030
Fig. 25 Insulin pumps market estimates and forecast, 2018 - 2030
Fig. 26 Patch pumps market estimates and forecast, 2018 - 2030
Fig. 27 Tethered pumps market estimates and forecast, 2018 - 2030
Fig. 28 Insulin pen needles market estimates and forecast, 2018 - 2030
Fig. 29 Standard pen needles market estimates and forecast, 2018 - 2030
Fig. 30 Safety pen needles market estimates and forecast, 2018 - 2030
Fig. 31 Insulin syringes market estimates and forecast, 2018 - 2030
Fig. 32 Other products market estimates and forecast, 2018 - 2030
Fig. 33 Insulin delivery devices market: End use movement analysis
Fig. 34 Insulin delivery devices market: End use outlook and key takeaways
Fig. 35 Hospitals and clinics market estimates and forecast, 2018 - 2030
Fig. 36 Homecare market estimates and forecast, 2018 - 2030
Fig. 37 Others end users market estimates and forecast, 2018 - 2030
Fig. 38 Global insulin delivery devices market: Regional movement analysis
Fig. 39 Global insulin delivery devices market: Regional outlook and key takeaways
Fig. 40 North America
Fig. 41 North America market estimates and forecasts, 2018 - 2030
Fig. 42 U.S.
Fig. 43 U.S. market estimates and forecasts, 2018 - 2030
Fig. 44 Canada
Fig. 45 Canada market estimates and forecasts, 2018 - 2030
Fig. 46 Mexico
Fig. 47 Mexico market estimates and forecasts, 2018 - 2030
Fig. 48 Europe
Fig. 49 Europe market estimates and forecasts, 2018 - 2030
Fig. 50 UK
Fig. 51 UK market estimates and forecasts, 2018 - 2030
Fig. 52 Germany
Fig. 53 Germany market estimates and forecasts, 2018 - 2030
Fig. 54 France
Fig. 55 France market estimates and forecasts, 2018 - 2030
Fig. 56 Italy
Fig. 57 Italy market estimates and forecasts, 2018 - 2030
Fig. 58 Spain
Fig. 59 Spain market estimates and forecasts, 2018 - 2030
Fig. 60 Denmark
Fig. 61 Denmark market estimates and forecasts, 2018 - 2030
Fig. 62 Sweden
Fig. 63 Sweden market estimates and forecasts, 2018 - 2030
Fig. 64 Norway
Fig. 65 Norway market estimates and forecasts, 2018 - 2030
Fig. 66 Asia Pacific
Fig. 67 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 68 China
Fig. 69 China market estimates and forecasts, 2018 - 2030
Fig. 70 Japan
Fig. 71 Japan market estimates and forecasts, 2018 - 2030
Fig. 72 India
Fig. 73 India market estimates and forecasts, 2018 - 2030
Fig. 74 Thailand
Fig. 75 Thailand market estimates and forecasts, 2018 - 2030
Fig. 76 South Korea
Fig. 77 South Korea market estimates and forecasts, 2018 - 2030
Fig. 78 Australia
Fig. 79 Australia market estimates and forecasts, 2018 - 2030
Fig. 80 Latin America
Fig. 81 Latin America market estimates and forecasts, 2018 - 2030
Fig. 82 Brazil
Fig. 83 Brazil market estimates and forecasts, 2018 - 2030
Fig. 84 Mexico
Fig. 85 Mexico market estimates and forecasts, 2018 - 2030
Fig. 86 Argentina
Fig. 87 Argentina market estimates and forecasts, 2018 - 2030
Fig. 88 Middle East and Africa
Fig. 89 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 90 South Africa
Fig. 91 South Africa market estimates and forecasts, 2018 - 2030
Fig. 92 Saudi Arabia
Fig. 93 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 94 UAE
Fig. 95 UAE market estimates and forecasts, 2018 - 2030
Fig. 96 Kuwait
Fig. 97 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 98 Market share of key market players- Insulin delivery devices market

Companies Mentioned

  • Novo Nordisk A/S
  • Sanofi
  • Eli Lilly and Company
  • Ypsomed AG
  • Medtronic
  • Insulet Corporation
  • B. Braun SE
  • Owen Mumford Ltd.
  • Tandem Diabetes Care, Inc.
  • BD

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 16.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 28.06 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Diabetes Devices Market Size, Share & Trends Analysis Report by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Diabetes Devices Market Size, Share & Trends Analysis Report by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 195 Pages
  • Global
From
Pediatric Diabetes Therapeutic Market Size, Share and Trends Analysis Report by Type (Type 1, Type 2), Treatment (Insulin, GLP-1, Biguanide, SGLT2), Route of Administration, Distribution Channel, and Region 2024-2030 - Product Image

Pediatric Diabetes Therapeutic Market Size, Share and Trends Analysis Report by Type (Type 1, Type 2), Treatment (Insulin, GLP-1, Biguanide, SGLT2), Route of Administration, Distribution Channel, and Region 2024-2030

  • Report
  • 110 Pages
  • Global
From
Insulin Delivery Devices Market by Product, End-User - Global Forecast 2025-2030 - Product Image

Insulin Delivery Devices Market by Product, End-User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Smart Insulin Pens & Pumps Market by Product, Usability, Application, End-Use - Global Forecast 2025-2030 - Product Image

Smart Insulin Pens & Pumps Market by Product, Usability, Application, End-Use - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Insulin Delivery Device - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Insulin Delivery Device - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.